Navigation Links
New Pixantrone Data Presented at Meetings at American Society of Hematology Conference
Date:12/6/2010

presentation at scientific meetings once median survival is reached in both treatment arms, to date median PFS has not yet been reached in the CPOP-R arm.

About PixantronePixantrone is a novel aza-anthracenedione that has distinct structural and physio-chemical properties that make its anti-tumor activity unique in this class of agents. Similar to anthracyclines, pixantrone inhibits Topo-isomerase II but unlike anthracyclines--rather than intercalation with DNA--pixantrone alkylates DNA--forming stable DNA adducts, with particular specificity for CpG rich, hyper-methylated sites. The Company believes that these structural differences resulted in significantly enhanced anti-lymphoma activity compared to doxorubicin in preclinical models. In addition, the Company believes the structural motifs on anthracycline-like agents that are responsible for the generation of oxygen free radicals and the formation of toxic drug-metal complexes have also been modified in pixantrone to prevent the binding of iron and perpetuation of superoxide production--both of which are the putative mechanism for anthracycline induced acute cardiotoxicity. These novel pharmacologic differences may allow re-introduction of anthracycline like potency in the treatment of relapsed/refractory aggressive lymphoma without unacceptable rates of cardiotoxicity.

About Cell Therapeutics, Inc.Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. For additional information, please visit www.CellTherapeutics.com.

Sign up for email alerts and get RSS feeds at our Web site, http://www.CellTherapeutics.com/investors_alert

This press release includes forward-looking statements that involve a number of risks and uncertainties, the outcome of which could mater
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. EMEA Validates Cell Therapeutics, Inc.s (CTI) Expanded Pixantrone Pediatric Investigation Plan (PIP)
2. Cell Therapeutics, Inc. (CTI) Advances Pixantrone Filing Process in Europe; Submits Pediatric Investigation Plan (PIP)
3. Cell Therapeutics Second Quarter Net Loss Decreases 54%; Pixantrone NDA Submitted to the FDA for Approval
4. Pixantrone Significantly Increases Complete Remissions, Overall Response Rates, Frequency of Durable Remissions and Progression Free Survival in Patients with Relapsed and Refractory Aggressive Non-Hodgkins Lymphoma
5. Low Occurrence of Severe Cardiac Side Effects Despite Extensive Prior Doxorubicin Treatment Reported in Pixantrone Pivotal Trial
6. Cell Therapeutics Targeting Potential Zevalin Label Expansion, Pixantrone and OPAXIO Drug Approvals to Grow Commercial Operations and Revenues in 2009
7. Alder Biopharmaceuticals Announces That Data From Multiple Studies of ALD518 (BMS945429), an Investigational Antibody Therapeutic in Rheumatoid Arthritis Patients, to be Presented at Annual Meeting of the American College of Rheumatology
8. Week-24 Interim Results From Phase 2b PILLAR Study to be Presented as Late-Breaker at AASLD
9. Investigational Data Presented for INTUNIV™ (guanfacine) Extended-Release Tablets When Coadministered With Stimulants Showed ADHD Symptom Improvement in Overall, Morning and Evening Assessments
10. Amgen Highlights Data to Be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting
11. Data on VIVUS QNEXA to be Presented in Six Posters at The Obesity Societys Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 2014 Riviera Beach, Florida based ... creation of the Sancilio Scientific Advisory Board (SSAB). ... philosophy of looking to nature for pharmaceutical advancements, ... are based on sound scientific data, analyses, expertise ... provides a vehicle for SCI to receive peer ...
(Date:8/27/2014)... 2014 According to the 2013 Raw ... the look and feel of markets for raw materials ... ingredients will push for more branded, science-backed products.” , ... strong market growth in the last decade as consumers ... and cosmetics to fit a more ‘wellness’ lifestyle approach. ...
(Date:8/27/2014)... 27, 2014 Budding Biomedical Scientists ... University School participated in the Scientific Enrichment ... University’s School of Medicine . , ... unparalleled professional experience in the sciences and brings ... faculty and students for both academic and career ...
(Date:8/26/2014)... San Diego, CA, and Bellingham, WA (PRWEB) August ... nanoscience and optical engineering, visions for next-generation wearable ... Light 2015 among numerous highlights at this year’s ... in the San Diego, California, Convention Center. More ... suppliers last week attended conferences, courses, an exhibition, ...
Breaking Biology Technology:New Sancilio & Company, Inc. Scientific Board 2New Sancilio & Company, Inc. Scientific Board 3Daring to be Different Raw Materials & Ingredient Supply Shortage Fuels Vital Force™ Technology New Ingredient Enhancements 2Daring to be Different Raw Materials & Ingredient Supply Shortage Fuels Vital Force™ Technology New Ingredient Enhancements 3Students at Cleveland's University School Conduct Biomedical Research at Case Western Reserve University’s School of Medicine 2Brighter, Busier SPIE Optics + Photonics Draws International Crowd to San Diego 2Brighter, Busier SPIE Optics + Photonics Draws International Crowd to San Diego 3Brighter, Busier SPIE Optics + Photonics Draws International Crowd to San Diego 4
... For Rejection Of Legislation That Will Cost Vermonters Current ... to the Legislature and a full page ad in ... that a bill under consideration by the Vermont Legislature ... for biotechnology growth and development not only in New ...
... April 24 Dendreon Corporation (Nasdaq: DNDN ... at the American Urological Association,s (AUA) Annual Meeting in ... conference call:, , ... CDT - "A randomized, double-blind, placebo-controlled, multi-center, phase III ...
... April 23 Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ... Lead Independent Director, on behalf of the Amylin Board of ... Carl Icahn and Eastbourne Capital Management, L.L.C. to find a ... can reach a resolution that will be in the best ...
Cached Biology Technology:Regional Biotech Association Warns Legislation Would Make VT Least Friendly State in Nation for Biotechnology and Life Sciences 2Dendreon Announces Data Presentations and Webcast at AUA Annual Meeting 2Amylin Issues Statement in Response to Carl Icahn 2
(Date:8/26/2014)... environmental and social problems such as global warming ... or does the burden fall on our failure ... to a new study in the Journal ... burden for solving global problems from governments to ... , "When businesses convince politicians to encourage responsible ...
(Date:8/26/2014)... People for the Ethical Treatment of Animals (PETA) and ... be in Prague this week at the 9th World ... Sciences presenting original research on alternatives to the use ... well as studies identifying problems with current laboratory oversight ... from August 24 to 28, 2014, PETA and PISC ...
(Date:8/25/2014)... years ago this month, one of the first U.S. ... State University campus, striking some 2,000 people. A university ... data gathered at the time to gain insight into ... virus,s rapid spread across the university community., The fall ... came in to the university,s Health and Wellness Services ...
Breaking Biology News(10 mins):An inconvenient truth: Does responsible consumption benefit corporations more than society? 2WSU flu outbreak provides rare study material 2WSU flu outbreak provides rare study material 3
... release is available in Spanish . First ... stink bug (BMSB) is now in at least 39 states, is ... threat to orchard fruits, garden vegetables and row crops. It,s no ... its top "invasive insect of interest." But help may ...
... 2013) Autism Speaks, the world,s leading autism science ... million in funding for 14 new research projects. To ... for research projects that advance understanding of the causes, ... "Autism Speaks continues in its steadfast ...
... Even as policy makers and health experts point to an ... and universities in the United States have dropped physical education ... student was required to take physical education and exercise requirements ... low of 39 percent, according to a new study. ...
Cached Biology News:Combating USDA's top-ranked invasive insect 2Autism Speaks awards $4.8 million for new research 2Autism Speaks awards $4.8 million for new research 3Autism Speaks awards $4.8 million for new research 4Autism Speaks awards $4.8 million for new research 5Physical education requirement at 4-year universities at all-time low 2Physical education requirement at 4-year universities at all-time low 3
No description available in Ensembl. Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
5(S)-HETE-d8 is used as an internal standard for the quantification of 5(S)-HETE by stable isotope dilution mass spectrometry....
Full-length cDNA clone CS0DJ013YG01 of T cells (Jurkat cell line) of Homo sapiens (human). [Source:Uniprot/SPTREMBL;Acc:Q86SZ3] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
...
Biology Products: